According to DataM Intelligence, the Cystic Fibrosis (CF) Therapeutics Market Size accelerated to USD 10.60 billion in 2024, up from USD ...
Patients with severe hypertriglyceridemia treated with olezarsen vs. placebo had a significantly greater decline in ...
After three bouts of pancreatitis over the last eight years, 37-year-old Brenda Minor took matters into her own hands. That ...
A study led by University of Cincinnati Cancer Center researchers sheds new light on how pancreatic cancer cells resist ...
Ulcerative colitis patients who discontinued 5-aminosalicylic acid (5-ASA) monotherapy have an increased risk of relapse, ...
An artificial intelligence (AI) system outperformed radiologists in detecting pancreatic ductal adenocarcinoma (PDAC) on ...
Patients with severe hypertriglyceridemia have an increased risk of acute pancreatitis. The efficacy and safety of olezarsen, an antisense oligonucleotide targeting apolipoprotein C-III messenger RNA, ...
Vertex Pharmaceuticals Incorporated ( VRTX) Citi Annual Global Healthcare Conference 2025 December 3, 2025 9:00 AM EST ...